Reporting potential conflicts of interest among authors of professional medical societies' guidelines

Southern Medical Journal

Volumn 105, Issue 8, 2012, Pages 411-415

  Khalil, Bassem ^a,b,c   Aung, Koko ^a,b,c   Mansi, Ishak A ^a,b,c  

^a UNION MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

conflicts of interest; ethics; medical societies

Indexed keywords

AUTHOR; CONFLICT OF INTEREST; HUMAN; INFORMATION DISSEMINATION; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; MEDICAL SOCIETY; PRACTICE GUIDELINE; PROFESSIONAL STANDARD; PUBLICATION; REVIEW; WRITING;

AUTHORSHIP; BIBLIOMETRICS; CONFLICT OF INTEREST; DISCLOSURE; HUMANS; ORGANIZATIONAL POLICY; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84864870960     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318256ef1d     Document Type: Review

References (28)

1. Chimonas S, Rothman DJ. New federal guidelines for physicianpharmaceutical industry relations: the politics of policy formation. Health Aff (Millwood) 2005;24:949-960. (Pubitemid 41058594)
2. Morris L, Taitsman JK. The agenda for continuing medical educationVlimiting industry's influence. N Engl JMed 2009;361:2478-2482.
3. Council of Medical Specialty Societies. Code for interactions with companies. http://www.cmss.org/codeforinteractions.aspx. Published March 19, 2011. Accessed February 14, 2012.
4. Drucker J. Beyond conflict of interest: maybe wrong questions are being asked. BMJ 2004;329:686. (Pubitemid 39279300)
5. Avraham R. Clinical practice guidelines: the warped incentives in the U.S. healthcare system. Am J Law Med 2011;37:7-40.
6. Nissen SE. Can we trust cardiovascular practice guidelines? Comment on ''Conflicts of interest in cardiovascular clinical practice guidelines.'' Arch Intern Med 2011;171:584-585.
7. Scott IA, Guyatt GH. Clinical practice guidelines: the need for greater transparency in formulating recommendations. Med JAust 2011;195:29-33.
8. Ornstein C,Weber T. Doctors' groups welcome medical company dollars. http://www.usatoday.com/money/industries/health/2011-05-05-medicalsocieties- sell-access-to-manufacturers-n.htm. Published May 6, 2011. Accessed February 15, 2012.
9. Rothman DJ, McDonald WJ, Berkowitz CD, et al. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA 2009;301:1367-1372.
10. Institute of Medicine. Clinical practice guidelines we can trust. http://www.iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust.aspx. Published March 23, 2011. Accessed February 15, 2012
11. Agency for Healthcare Research and Quality. National Guideline Clearinghouse. Criteria for inclusion of clinical practice guidelines. www.guideline.gov/about/inclusion-criteria.aspx. Accessed March 5, 2011.
12. Mendelson TB, Meltzer M, Campbell EG, et al. Conflicts of interest in cardiovascular clinical practice guidelines. Arch Intern Med 2011;171: 577-584.
13. Baumann MH, Lewis SZ, Gutterman D. ACCP evidence-based guideline development: a successful and transparent approach addressing conflict of interest, funding, and patient-centered recommendations. Chest 2007;132:1015-1024.
14. Schunemann HJ, Osborne M, Moss J, et al. An official American Thoracic Society Policy statement: managing conflict of interest in professional societies. Am J Respir Crit Care Med 2009;180:564-580.
15. Wood S. Studies linking drug-eluting stents to increased mortality/MI spark impassioned pleas for reason and calls for calm. http://www.theheart.org/ article/736863.do. Published September 3, 2006. Accessed June 10, 2011.
16. Thomas M. Interventional cardiology and the medical devices industry: is there a conflict of interest? Heart 2007;93:1351-1352. (Pubitemid 351480128)
17. CamilleriM, ParkeDW2nd.Perspective: conflict of interest and professional organizations: considerations and recommendations Acad Med 2010 85 85-91.
18. McCrary SV, Anderson CB, Jakovljevic J, et al. A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med 2000;343:1621-1626. (Pubitemid 32162987)
19. Clark J, Gonzalez J, Mansi B, et al. Enhancing transparency and efficiency in reporting industry-sponsored clinical research: report from the Medical Publishing Insights and Practices initiative. Int J Clin Pract 2010;64: 1028-1033.
20. Lowes R. WHO says failure to disclose conflict of interests of pandemic advisors was an ''oversight.'' www.medscape.com/viewarticle/723191-print. Published June 8, 2010. Accessed June 10, 2010.
21. White PF. Consensus guidelines for managing postoperative nausea and vomiting: is there a conflict of interest? Anesth Analg 2004;98:550-551.
22. Edwards IR. Conflicts of interest in medicines safety and regulation: how much conflict and how much interest should we allow? Drug Saf 2011;34:617-621.
23. Okike K, Kocher MS, Wei EX, et al. Accuracy of conflict-of-interest disclosures reported by physicians. N Engl J Med 2009;361:1466-1474.
24. Psaty BM. Conflict of interest, disclosure, and trial reports. JAMA 2009;301:1477-1479.
25. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001;110:551-557.
26. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003;290:252-255. (Pubitemid 37430065)
27. Aron D, Pogach L. Transparency standards for diabetes performance measures. JAMA 2009;301:210-212.
28. Ferris LE, Fletcher RH. Conflict of interest in peer-reviewed medical journals: the World Association of Medical Editors (WAME) position on a challenging problem. Neurosurgery 2010;66:629-630.